Advertisement

Challenges in Fertility Counseling of Cancer Patients: A Developing Nation Perspective

  • Ghina GhazeeriEmail author
  • Dalia Khalife
Chapter

Abstract

The loss of fertility is devastating for patients in the reproductive age group. Counseling about fertility preservation (FP) varies extensively in developing countries and is bounded by many challenges. Many physicians are not used to involving patients in the decision-making process, where the whole family might be involved in the consultation. Consequently, reproductive concerns are not always addressed.

Thus, unique challenges are faced by health care providers in developing nations including the costs of FP procedures, time constraints, religious, cultural beliefs, and legal requirements that will be reviewed in this chapter.

Keywords

Counseling Fertility preservation Cancer Health care providers Developing nations 

References

  1. 1.
    Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–31.CrossRefGoogle Scholar
  2. 2.
    Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500.CrossRefGoogle Scholar
  3. 3.
    Becht LC, Forman EJ. Navigating the complex challenges of fertility preservation. Fertil Steril. 2018;109(2):252–3.CrossRefGoogle Scholar
  4. 4.
    Connell S, Patterson C, Newman B. A qualitative analysis of reproductive issues raised by young Australian women with breast cancer. Health Care Women Int. 2006;27(1):94–110.CrossRefGoogle Scholar
  5. 5.
    Blumenfeld Z, Haim N. Prevention of gonadal damage during cytotoxic therapy. Ann Med. 1997;29(3):199–206.CrossRefGoogle Scholar
  6. 6.
    Peate M, Meiser B, Hickey M, Friedlander M. The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat. 2009;116(2):215.CrossRefGoogle Scholar
  7. 7.
    Kirkman M, Winship I, Stern C, Neil S, Mann GB, Fisher JR. Women’s reflections on fertility and motherhood after breast cancer and its treatment. Eur J Cancer Care. 2014;23(4):502–13.CrossRefGoogle Scholar
  8. 8.
    Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: Committee on Cancer Survivorship: Improving Care and Quality of Life, National Cancer Policy Board, Institute of Medicine, and National Research Council; 2006.Google Scholar
  9. 9.
    Davis M. Fertility considerations for female adolescent and young adult patients following cancer therapy: a guide for counseling patients and their families. Clin J Oncol Nurs. 2006;10(2):213.CrossRefGoogle Scholar
  10. 10.
    Centers for Disease Control and Prevention. American Society for Reproductive Medicine, and Society for Assisted Reproductive Technology. 2006 Assisted reproductive technology success rates: National summary and fertility clinic reports; 2008Google Scholar
  11. 11.
    Rashedi AS, SFD R AL, Edmonds ME. Survey of third-party parenting options associated with fertility preservation available to patients with cancer around the globe. J Glob Oncol. 2017;  https://doi.org/10.1200/JGO.2017.009944.
  12. 12.
    Whitworth A. Freezing embryos—a woman’s best option, but is it legal? J Natl Cancer Inst. 2006;98(19):1359.CrossRefGoogle Scholar
  13. 13.
    Rabah DM, El-Nimr N, Rafe BA, Arafa MA. Fertility cryopreservation for female cancer patients: attitudes and clinical practices of oncologists in Riyadh, Saudi Arabia. J Reprod Med. 2012;57(9-10):431–4.PubMedGoogle Scholar
  14. 14.
    Ghazeeri G, Zebian D, Nassar AH, Harajly S, Abdallah A, Hakimian S, Skaiff B, Abbas HA, Awwad J. Knowledge, attitudes and awareness regarding fertility preservation among oncologists and clinical practitioners in Lebanon. Hum Fertil. 2016;19(2):127–33.CrossRefGoogle Scholar
  15. 15.
    Rabah DM, Wahdan IH, Merdawy A, Abourafe B, Arafa MA. Oncologists’ knowledge and practice towards sperm cryopreservation in Arabic communities. J Cancer Surviv. 2010;4(3):279–83.CrossRefGoogle Scholar
  16. 16.
    Quinn GP, Vadaparampil ST. Fertility preservation and adolescent/young adult cancer patients: physician communication challenges. J Adolesc Health. 2009;44(4):394–400.CrossRefGoogle Scholar
  17. 17.
    Moravek MB, Confino R, Smith KN, Kazer RR, Klock SC, Lawson AK, Gradishar WJ, Pavone ME. Long-term outcomes in cancer patients who did or did not pursue fertility preservation. Fertil Steril. 2018;109(2):349–55.CrossRefGoogle Scholar
  18. 18.
    Letourneau JM, Sinha N, Wald K, Harris E, Quinn M, Imbar T, Mok-Lin E, Chien AJ, Rosen M. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer. Hum Reprod. 2017;32(10):2123–9.CrossRefGoogle Scholar
  19. 19.
    Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100(6):1673–80.CrossRefGoogle Scholar
  20. 20.
    Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91(10):3885–90.CrossRefGoogle Scholar
  21. 21.
    American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 405: ovarian tissue and oocyte cryopreservation. Obstet Gynecol. 2008;111(5):1255–6.CrossRefGoogle Scholar
  22. 22.
    Nachtigall RD. International disparities in access to infertility services. Fertil Steril. 2006;85(4):871–5.CrossRefGoogle Scholar
  23. 23.
    Rashedi AS, de Roo SF, Ataman LM, Edmonds ME, Silva AA, Scarella A, Horbaczewska A, Anazodo A, Arvas A, Ramalho de Carvalho B, Sartorio C. Survey of fertility preservation options available to patients with cancer around the globe. J Glob Oncol. 2017;4:1–6.PubMedGoogle Scholar
  24. 24.
    Jones G, Hughes J, Mahmoodi N, Smith E, Skull J, Ledger W. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment? Hum Reprod Update. 2017;23(4):433–57.CrossRefGoogle Scholar
  25. 25.
    Larijani B, Zahedi F. Ethical and religious aspects of gamete and embryo donation and legislation in Iran. J Relig Health. 2007;46(3):399–408.CrossRefGoogle Scholar
  26. 26.
    Samani RO, Ashrafi M, Alizadeh L, Mozafari M. Posthumous assisted reproduction from Islamic perspective. Int J Fertil Steril. 2008;2(2)Google Scholar
  27. 27.
    Schenker JG. Assisted reproduction practice: religious perspectives. Reprod Biomed Online. 2005;10(3):310–9.CrossRefGoogle Scholar
  28. 28.
    Purvis TE. Assisted reproduction in Indonesia: policy reform in an Islamic culture and developing nation. Reprod Biomed Online. 2015;31(5):697–705.CrossRefGoogle Scholar
  29. 29.
    Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril. 2018;110(3):380–6.CrossRefGoogle Scholar
  30. 30.
    Crockin SL. Legal issues related to parenthood after cancer. JNCI Monogr. 2005;(34):111–3.CrossRefGoogle Scholar
  31. 31.
    Robertson JA. Cancer and fertility: ethical and legal challenges. JNCI Monogr. 2005;(34):104–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and GynecologyAmerican University of Beirut Medical CenterBeirutLebanon

Personalised recommendations